"Navigating the Modern News Zoo so you don't have to."
Friday, April 18, 2025
Q&A: Study shows promise for treating progressive multiple sclerosis
New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine suggests that a therapy called Tolebrutinib could reduce disability progression in people with non-relapsing progressive multiple sclerosis (MS)—a subtype of MS that doesn't respond well to current disease-modifying therapies.
Black Women In Chicago Attack Waitress Over $50 REFUND in Mexican Restaurant
- Mother allegedly arrested after confiscating her children's iPads
- Angela Bassett & Tim Minear Dissect ‘9-1-1’ Shocker & Its Fallout And Explain Why [Spoiler] Had To Die - Nellie Andreeva
- Ramp is trying to get the US government as a customer after seeing a tweet from DOGE - Mary Ann Azevedo
- DALL-E Free: The Future of Image Creation is Here - seo
- Activist Connected To Karmelo Anthony Reportedly Has Lengthy Criminal History, Including Domestic Abuse Allegations - Ilan Hulkower
- Oral Cancer and Soda—New Research Suggests There May Be a Link - Brian Mastroianni
Android Fanboy Tries the Most Hated iPhone!
- OpenAI Welcomes Sam Altman Back as CEO with a Reformed Board Structure - Sean George
- Study finds that disabling internet on your cell phone could reverse brain aging
- The Crohn’s Conversation: 6 Tips for Sharing Your Diagnosis With a New Partner - Jenna Anderson
- Tesla Vandalism Update #3
- Car Dealerships Are Running ‘Tariff Sales’ as Shoppers Scramble to Buy
- Star Citizen's Astounding $48,000 DLC: An Analysis - Michael A. Medeiros
